Stocks of Edwards Lifesciences - Current price, Where to buy? Chart
| Detail | Data |
|---|---|
| Stocks: | Edwards Lifesciences |
| ompany Name: | Edwards Lifesciences Corporation |
| Ticker: | EW |
| Exchange: | NYSE |
| Outstanding stocks: | 601,926,976 |
| 24-hour Volume: | 0 |
| Industry: | |
| Sector: | |
| Number of Employees: | |
| Country: | |
| City: | |
| Address: |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| / | / | / | / | / | 52,199,108,608.00 USD |
| P/E Ratio: | / |
|---|---|
| Forward P/E: | / |
| EPS: | / |
| Forward EPS: | / |
| Book value per share: | / |
| Market capitalization: | 52,199,108,608.00 USD |
Edwards Lifesciences
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | / |
| Net Income: | / |
| Price-to-Book (P/B) Ratio: | / |
| PEG Ratio: | / |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | No recommendation has been issued for Edwards Lifesciences stocks by analysts. |
| Number of Analysts: | Edwards Lifesciences stocks are not covered by analysts. |
| Highest Target Price: | / |
| Lowest Target Price: | / |
| Average Target Price: | / |
Note: The data is approximate. Recommendations and price forecasts for Edwards Lifesciences stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | According to our data, the company Edwards Lifesciences is currently not paying dividends. |
| Annual Yield %: | - |
| Ex-dividend Date: | - |
| Average % Yield for 5 Years: | - |
| Payout Ratio: | - |
| Value of Last Dividend Paid: | - |
| Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Edwards Lifesciences Stocks?
If you're interested in investing in Edwards Lifesciences stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Edwards Lifesciences stocks through mobile apps with client support. In this table, you can compare brokers offering real Edwards Lifesciences stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about Edwards Lifesciences (EW)
Revenues of 0.00 USD indicate room for growth and improvement for Edwards Lifesciences. This presents an opportunity for further development. Negative EBITDA of 0.00 USD may indicate challenges but also opportunities for Edwards Lifesciences to invest in future growth. Debt-to-equity ratio of 0.00 suggests that Edwards Lifesciences has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 0.00% indicates room for Edwards Lifesciences to improve cost efficiency and competitiveness. Lower profit margin of 0.00% suggests opportunities for Edwards Lifesciences to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | / |
| EBITDA: | / |
| Earnings Per Share: | / |
| Book Value Per Share: | / |
| Total Cash: | / |
| Total Cash per Share: | / |
| Total Debt: | / |
| Debt to Equity Ratio: | / |
| Quick Ratio: | / |
| Current Ratio: | / |
| Free Cash Flow: | / |
| Operating Cash Flow: | / |
| Company Margins | |
| Gross Margins: | / |
| EBITDA Margins: | / |
| Operating Margins: | / |
| Profit Margins: | / |
| Performance | |
| Return on Assets: | / |
| Return on Equity: | / |
| Earnings Growth (1 year): | / |
| Revenue Growth (1 year): | / |
| Year-over-Year Quarterly Earnings Growth: | / |
| Valuation | |
| Market Capitalization: | 52,199,108,608.00 USD |
| Enterprise Value: | / |
| EV/Revenue: | / |
| EV/EBITDA: | / |
| Number of Shares and Short Shares | |
| Float Shares: | / |
| Shares Outstanding: | / |
| Held Percent Insiders: | / |
| Held Percent Institutions: | / |
| Shares Short: | / |
| Shares Short Prior Month: | / |
| Date Short Interest: | / |
| Shares Percent Shares Out: | / |
| Short Ratio: | / |
| Beta: | / |
| Short Percent of Float: | / |
| Předpokládaný počet akcií: | / |
Frequently Asked Questions (FAQ)
According to our data, Edwards Lifesciences does not currently pay dividends, even in 2024.
Edwards Lifesciences shares are traded on the stock exchange NYSE under the ticker symbol: EW. You can buy or trade them with a variety of stock brokers offering real stock trading services.
There has been no prediction or recommendation issued for Edwards Lifesciences shares yet.
The total number of Edwards Lifesciences shares on the exchange is 0.00, which, at the current market capitalization, values the company at 52,199,108,608.00 USD.
